2018 Belgian guidelines for the screening for latent tuberculosis in HIV-infected patients
Wyndham-Thomas C, Dirix V, Goffard JC, Henrard S, Wanlin M, Callens S, Mascart F, Van Vooren JP
Acta clinica Belgica · 2018-07
Abstract
Objectives : To review the current knowledge on screening for latent tuberculosis infection (LTBI) in HIV-infected adults and provide specific guidelines for Belgium. Focus is given to who to test, which testing method to use, timing of screening and choice of LTBI treatment. Methods : Expert review by the members of the Belgian LTBI group, in consultancy with the ARC College. Results : Target population, timing of screening, testing method, active TB exclusion, treatment of LTBI and guideline implementation are all reviewed. Conclusions : The principal changes include a selective approach to screen for LTBI (screening only of the HIV-infected patients at highest risk of active TB) as well as the timing of screening (testing for LTBI performed only after immune-restauration by antiretroviral therapy).
MeSH terms
- Humans
- Mycobacterium tuberculosis
- HIV Infections
- Mass Screening
- Tuberculin Test
- Antiretroviral Therapy, Highly Active
- Incidence
- Risk Assessment
- Risk Factors
- Adult
- Patient Care Management
- Belgium
- Female
- Male
- Latent Tuberculosis
- Interferon-gamma Release Tests